Northern Trust Corp Citius Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 319,356 shares of CTXR stock, worth $827,132. This represents 0.0% of its overall portfolio holdings.

Number of Shares

319,356

Previous 1,055,038 69.73%

Holding current value

$827,132

Previous $611,000 73.98%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$0.48 - $1.02 $353,127 - $750,395	-735,682 Reduced 69.73%	319,356 $159,000
Q2 2024 Aug 14, 2024	SELL	$0.58 - $1.03 $37,845 - $67,208	-65,251 Reduced 5.82%	1,055,038 $611,000
Q1 2024 May 14, 2024	BUY	$0.6 - $0.9 $45,092 - $67,638	75,154 Added 7.19%	1,120,289 $1.01 Million
Q4 2023 Feb 13, 2024	SELL	$0.65 - $0.86 $5,934 - $7,851	-9,130 Reduced 0.87%	1,045,135 $794,000
Q3 2023 Nov 13, 2023	BUY	$0.65 - $1.25 $16,645 - $32,011	25,609 Added 2.49%	1,054,265 $716,000
Q2 2023 Aug 11, 2023	BUY	$1.08 - $1.65 $846,088 - $1.29 Million	783,415 Added 319.45%	1,028,656 $1.23 Million
Q1 2023 May 15, 2023	BUY	$0.78 - $1.42 $5,466 - $9,951	7,008 Added 2.94%	245,241 $286,000
Q3 2022 Nov 14, 2022	SELL	$0.14 - $1.33 $64 - $611	-460 Reduced 0.19%	238,233 $289,000
Q2 2022 Aug 12, 2022	SELL	$0.88 - $1.87 $725,757 - $1.54 Million	-824,724 Reduced 77.55%	238,693 $220,000
Q1 2022 May 13, 2022	BUY	$1.38 - $1.89 $87,701 - $120,113	63,552 Added 6.36%	1,063,417 $1.9 Million
Q4 2021 Feb 08, 2022	SELL	$1.51 - $2.2 $34,251 - $49,902	-22,683 Reduced 2.22%	999,865 $1.54 Million
Q3 2021 Nov 15, 2021	SELL	$1.74 - $2.6 $480,172 - $717,498	-275,961 Reduced 21.25%	1,022,548 $2.08 Million
Q2 2021 Aug 13, 2021	BUY	$1.51 - $4.23 $1.63 Million - $4.55 Million	1,076,263 Added 484.27%	1,298,509 $4.52 Million
Q1 2021 May 12, 2021	BUY	$1.04 - $2.34 $151,028 - $339,814	145,220 Added 188.53%	222,246 $396,000
Q4 2020 Feb 11, 2021	BUY	$0.9 - $1.2 $31,635 - $42,181	35,151 Added 83.94%	77,026 $79,000
Q3 2020 Nov 16, 2020	BUY	$0.83 - $1.51 $8,804 - $16,018	10,608 Added 33.93%	41,875 $44,000
Q2 2020 Aug 14, 2020	BUY	$0.65 - $1.45 $9,308 - $20,764	14,320 Added 84.5%	31,267 $35,000
Q1 2020 May 14, 2020	BUY	$0.46 - $1.3 $7,795 - $22,031	16,947 New	16,947 $10,000

Others Institutions Holding CTXR

# of Institutions

Shares Held

23.7M

Call Options Held

83.1K

Put Options Held

32.1K

View Full List

About Citius Pharmaceuticals, Inc.

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $378M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

More about CTXR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Citius Pharmaceuticals, Inc. Transaction History